Form 4: ACM Research Director Xiao Xing Sells Shares Under 10b5-1 Trading Plan

Director Xiao Xing, an employee of an affiliate of Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC), sold shares of ACM Research, Inc. under a pre-arranged 10b5-1 trading plan.

Summary

• Xiao Xing, a director of ACM Research, Inc., reported the sale of Class A Common Stock on multiple dates in October 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted by Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC) on June 12, 2024.
• On October 4, 2024, 580,873 shares were sold at a weighted average price of $21.33, and 119,127 shares were sold at a weighted average price of $21.79.
• On October 7, 2024, 173,005 shares were sold at a weighted average price of $23.32, 101,018 shares were sold at a weighted average price of $25.35, and 977 shares were sold at a weighted average price of $26.01.
• On October 8, 2024, 90,396 shares were sold at a weighted average price of $21.13.
• Following these transactions, the number of indirectly beneficially owned shares is 2,338,510.
• The shares are owned by SSTVC, and Xiao Xing disclaims beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document reports routine stock sales under a pre-existing trading plan. There is no indication of positive or negative implications for the company's performance.

Industry Context

Sales by company directors are a normal part of business. The fact that these sales were executed under a pre-arranged 10b5-1 trading plan suggests that the sales were planned in advance and not based on any inside information.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates